Drug
Efinaconazole clinical trials
Also written Jublia and IDP-108.
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 2
University of Alabama at Birmingham (2) · Dow Pharmaceutical Sciences (2) · Bausch Health Americas, Inc. (1) · Dong-A ST Co., Ltd. (1)
Studies
Open first, then newest update. How each study uses efinaconazole is read from its arms, and is right about nine times in ten.
Testing it · 6
- Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe OnychomycosisCompletedPhase 4Bausch Health Americas, Inc.NCT02812771Written as Efinaconazole
- Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail OnychomycosisCompletedPhase 4Dong-A ST Co., Ltd.NCT03280927Written as Jublia®
- Real-World Evaluation of the Effect of Jublia on Nail PolishCompletedNot applicableUniversity of Alabama at BirminghamNCT03022916Written as Nail Polish + Efinaconazole Solution
- Study Evaluating the Effect of Jublia on DermatophytomasCompletedPhase 4University of Alabama at BirminghamNCT03098615Written as Jublia (Efinaconazole 10% Topical Solution)
- The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With OnychomycosisCompletedPhase 3Dow Pharmaceutical SciencesNCT01007708Written as IDP-108
- Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With OnychomycosisCompletedPhase 3Dow Pharmaceutical SciencesNCT01008033Written as IDP-108
Given in every arm · 1 — efinaconazole is usual care beside what is tested
As the comparator · 1 — what is tested is compared with efinaconazole
Codes
What other systems call efinaconazole · ClinicalTrials.gg INT004364
- MeSH (NLM) C431707efinaconazoleConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) J82SB7FXWBEFINACONAZOLEConfirmed FDA, NLM, Wikidata
- RxNorm 1539753Confirmed FDA, Wikidata
- Wikidata Q21011225efinaconazoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C97998EfinaconazoleOne source FDA
- DrugBank DB09040One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C431707 | efinaconazole | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | J82SB7FXWB | EFINACONAZOLE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1539753 | — | Confirmed FDA, Wikidata |
| Wikidata | Q21011225 | efinaconazole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C97998 | Efinaconazole | One source FDA |
| DrugBank | DB09040 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.